Comment on

• Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1.

  Jia Y, Ding X, Zhou L, Zhang L, Yang X. Jia Y, et al. Oncogene. 2021 Jan;40(2):246-261. doi: 10.1038/s41388-020-01486-7. Epub 2020 Oct 29. Oncogene. 2021. Retraction in: Oncogene. 2023 Jul;42(28):2235. doi: 10.1038/s41388-023-02726-2. PMID: 33122828 Retracted.
• Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer.

  Zhang B, Li Y, Wu Q, Xie L, Barwick B, Fu C, Li X, Wu D, Xia S, Chen J, Qian WP, Yang L, Osunkoya AO, Boise L, Vertino PM, Zhao Y, Li M, Chen HR, Kowalski J, Kucuk O, Zhou W, Dong JT. Zhang B, et al. Nat Commun. 2021 Mar 17;12(1):1714. doi: 10.1038/s41467-021-21976-w. Nat Commun. 2021. PMID: 33731701 Free PMC article.
• A glutaminase isoform switch drives therapeutic resistance and disease progression of prostate cancer.

  Xu L, Yin Y, Li Y, Chen X, Chang Y, Zhang H, Liu J, Beasley J, McCaw P, Zhang H, Young S, Groth J, Wang Q, Locasale JW, Gao X, Tang DG, Dong X, He Y, George D, Hu H, Huang J. Xu L, et al. Proc Natl Acad Sci U S A. 2021 Mar 30;118(13):e2012748118. doi: 10.1073/pnas.2012748118. Proc Natl Acad Sci U S A. 2021. PMID: 33753479 Free PMC article.